Evaluation of the EMPAR study population on the basis of metabolic phenotypes of selected pharmacogenes.
Fracowiak J, Huebner T, Heß S, Roethlein C, Langner D, Schneider U, Falkenberg F, Scholl C, Linder R, Stingl J, Haenisch B, Steffens M.
Fracowiak J, et al. Among authors: linder r.
Pharmacogenomics J. 2022 Mar;22(2):136-144. doi: 10.1038/s41397-022-00268-6. Epub 2022 Jan 31.
Pharmacogenomics J. 2022.
PMID: 35102241
Free PMC article.
Review.